Amlamax™ in the Management of Dyslipidemia in Humans

  title={Amlamax™ in the Management of Dyslipidemia in Humans},
  author={Benny Antony and B. Merina and V. Sheeba},
  booktitle={Indian journal of pharmaceutical sciences},
Hypercholesterolemia is the major cause of cardiovascular diseases leading to myocardial infarctions leading to considerable morbidity and mortality. During the past decade a group of molecules referred to as statins such as simvastatin, atrovastatin have been tried with great success in reducing total cholesterol. These molecules act by inhibiting the HMG CoA reductase enzyme thereby interfering with the synthesis of cholesterol. But statins reduce all the cholesterol including HDL cholesterol… CONTINUE READING